Literature DB >> 8762804

Response to intravenous midazolam sedation in general dental practice.

S Ellis.   

Abstract

The object of this study was to grade the response of patients undergoing a variety of dental procedures with the aid of intravenous midazolam sedation in general dental practice and to explore any relationships between the patients preoperative anxiety assessment and the clinician's assessment of co-operation whilst under sedation. One hundred consecutive patients aged between 18 and 58 years (mean 32 years; sd 10 years) and in ASA Class I or II were prospectively studied. Results showed that despite attempts to grade patient's behaviour it was not possible to reliably predict patient's responses under intravenous sedation. In addition to these findings, the great individual variation in sensitivity to midazolam was confirmed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8762804     DOI: 10.1038/sj.bdj.4809108

Source DB:  PubMed          Journal:  Br Dent J        ISSN: 0007-0610            Impact factor:   1.626


  4 in total

1.  A comparison of the sedative effect of oral versus nasal midazolam combined with nitrous oxide in uncooperative children.

Authors:  I E Musani; N V Chandan
Journal:  Eur Arch Paediatr Dent       Date:  2015-05-05

2.  Comparison of the Sedative Effect of Inhaled Nitrous Oxide and Intranasal Midazolam in Behavior Management and Pain Perception of Pediatric Patients: A Split-mouth Randomized Controlled Clinical Trial.

Authors:  Navaneetha Krishnan Srinivasan; Pradeep Karunagaran; Veerale Panchal; Emg Subramanian
Journal:  Int J Clin Pediatr Dent       Date:  2021

3.  Intravenous sedation as an adjunct to advanced comprehensive dental implantology: the patient's perspective and operator satisfaction.

Authors:  S J J McCrea
Journal:  Br Dent J       Date:  2015-03-13       Impact factor: 1.626

4.  The effects of preoperative anxiety on intravenous sedation.

Authors:  Timothy M Osborn; Noah A Sandler
Journal:  Anesth Prog       Date:  2004
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.